← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$25K

Shares

1,752

Price

$14

Filed

Jun 30

Why this score? (8/10)
  • Open market buy (+3)
  • % of holdings >= 50% (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Valantine Hannah

Title

CIK

0001855608

Roles

Director

Transaction Details

Transaction Date

2021-12-29

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,294

Filing Info

Accession No.

0000950170-25-091759

Form Type

4/A

Issuer CIK

0001743881

Valantine Hannah's History

Date Ticker Type Value
2025-06-26 BBIO $39K
2025-06-26 BBIO $68K
2025-06-26 BBIO $18K
2025-06-26 BBIO $83K
2025-06-20 BBIO A $0
2025-06-20 BBIO A $0
2025-06-18 CDNA $203K
2025-06-13 CDNA A $0
2025-06-10 BBIO M $72K
2025-06-10 BBIO $172K

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$6.0M 2026-04-10